Marshall Wace’s Pacira BioSciences PCRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.55M | Buy |
+190,366
| New | +$4.55M | 0.01% | 1092 |
|
|
2025
Q1 | – | Sell |
-42,613
| Closed | -$803K | – | 2798 |
|
|
2024
Q4 | $803K | Sell |
42,613
-482,336
| -92% | -$9.09M | ﹤0.01% | 1705 |
|
|
2024
Q3 | $7.9M | Sell |
524,949
-446,194
| -46% | -$6.72M | 0.01% | 776 |
|
|
2024
Q2 | $27.8M | Buy |
971,143
+159,791
| +20% | +$4.57M | 0.04% | 367 |
|
|
2024
Q1 | $23.7M | Buy |
811,352
+331,159
| +69% | +$9.68M | 0.04% | 401 |
|
|
2023
Q4 | $16.2M | Sell |
480,193
-5,452
| -1% | -$184K | 0.03% | 458 |
|
|
2023
Q3 | $14.9M | Buy |
485,645
+97,348
| +25% | +$2.99M | 0.03% | 473 |
|
|
2023
Q2 | $15.6M | Buy |
388,297
+69,136
| +22% | +$2.77M | 0.03% | 500 |
|
|
2023
Q1 | $13M | Buy |
319,161
+193,804
| +155% | +$7.91M | 0.03% | 529 |
|
|
2022
Q4 | $4.84M | Buy |
125,357
+82,396
| +192% | +$3.18M | 0.01% | 1033 |
|
|
2022
Q3 | $2.29M | Buy |
42,961
+24,638
| +134% | +$1.31M | 0.01% | 1499 |
|
|
2022
Q2 | $1.07M | Buy |
+18,323
| New | +$1.07M | ﹤0.01% | 1848 |
|
|
2022
Q1 | – | Sell |
-205,322
| Closed | -$12.4M | – | 3131 |
|
|
2021
Q4 | $12.4M | Buy |
205,322
+190,381
| +1,274% | +$11.5M | 0.02% | 664 |
|
|
2021
Q3 | $837K | Buy |
+14,941
| New | +$837K | ﹤0.01% | 1638 |
|
|
2021
Q2 | – | Sell |
-30,624
| Closed | -$2.15M | – | 2429 |
|
|
2021
Q1 | $2.15M | Buy |
+30,624
| New | +$2.15M | 0.01% | 1116 |
|
|
2020
Q1 | – | Sell |
-19,673
| Closed | -$891K | – | 1919 |
|
|
2019
Q4 | $891K | Sell |
19,673
-253,489
| -93% | -$11.5M | 0.01% | 971 |
|
|
2019
Q3 | $10.4M | Buy |
+273,162
| New | +$10.4M | 0.08% | 264 |
|
|
2016
Q4 | – | Sell |
-10,749
| Closed | -$368K | – | 1090 |
|
|
2016
Q3 | $368K | Buy |
+10,749
| New | +$368K | ﹤0.01% | 833 |
|
|
2015
Q4 | – | Sell |
-54,226
| Closed | -$2.23M | – | 1087 |
|
|
2015
Q3 | $2.23M | Buy |
+54,226
| New | +$2.23M | 0.03% | 426 |
|